AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Sign up Log in

Lexaria Bioscience Corp. Director's Dealing 2015

Aug 4, 2015

34983_dirs_2015-08-04_c74f72af-9e15-403b-93e0-2c3dfd5b6e6d.zip

Director's Dealing

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: LEXARIA CORP. (LXRP)
CIK: 0001348362
Period of Report: 2010-01-20

Reporting Person: BUNKA CHRISTOPHER (Director, CEO, 10% Owner)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2015-07-31	Common Shares	P	10000	$0.168	Acquired	4800230	Direct
2015-07-31	Common Shares	P	6000	$0.17	Acquired	4806230	Direct
2015-07-31	Common Shares	P	11000	$0.172	Acquired	4817230	Direct
2015-07-31	Common Shares	P	5000	$0.173	Acquired	4822230	Direct
2015-07-31	Common Shares	P	5000	$0.174	Acquired	4827230	Direct
2015-08-03	Common Shares	P	10000	$0.1734	Acquired	4837230	Direct
2015-08-04	Common Shares	P	1000	$0.17	Acquired	4838230	Direct
2015-08-04	Common Shares	P	5000	$0.155	Acquired	4843230	Direct

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Shares	4488958	Indirect
Common Shares	4790230	Direct

Holdings (Derivative)

Security	Exercise Price	Expiration	Underlying	Shares	Ownership
Stock Options	$0.11	2019-12-23	Common Shares (500000)	500000	Direct
Stock Options	$0.35	2016-07-11	Common Shares (200000)	700000	Direct
Stock Options	$0.1	2018-06-18	Common Shares (225000)	925000	Direct
Warrants	$0.25	2015-09-21	Common Shares (100067)	1025067	Direct
Warrants	$0.25	2017-05-15	Common Shares (170000)	170000	Indirect